Tailor your cell culture platform to achieve your research objectives & scale requirements

Cell & Gene Therapy Insights 2022; 8(8), 1243;

DOI: 10.18609/cgti.2022.181

Published: 4 November 2022

Ann Rossi Bilodeau graduated from the University of Rochester School of Medicine and Dentistry with a PhD in Pharmacology and received postdoctoral training at the University of Chicago. Ann began her career with Corning Life Sciences as Applications Lab Manager, utilizing her strong academic and industry research experience to direct the activities of the Applications Laboratory. Currently, she is the Senior Bioprocess Applications Scientist, functioning as the technical lead for generating applications in support of Corning Life Sciences’ Bioprocess and Cell/Gene Therapy portfolios including CellCube® and HYPERStack® platforms.